CHF-6366 is a potent M3 muscarinic antagonist and beta2-adrenergic receptors agonist with pKi values of 10.4 and 11.4, respectively. CHF-6366 is also a weak calcium channel inhibitor (IC50~50 µM). CHF-6366 inhibits bronchoconstriction in guinea pigs. CHF-6366 can be used to research chronic obstructive pulmonary disease (COPD)[1].
Molecular Weight:
764.87
CAS Number:
[1615208-41-7]
Formula:
C42H48N6O8
Target:
Adrenergic Receptor,Calcium Channel,mAChR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted